Vali is a venture-backed biotechnology startup founded in 2013 to develop smart, programmable drug delivery systems. Our patent-pending multidrug-delivery platform technology can transport multiple drugs to tumors simultaneously, unlocking previously impossible cancer combination therapies. We can deliver therapeutic nucleotides (siRNA, mRNA, DNA) in addition to traditional small molecule drugs. Our next generation technology will activate payloads only when they are delivered to the correct cell type, giving an unprecedented level of specificity, efficacy and safety.
YOU MIGHT ALSO BE INTERESTED IN